InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,709.54
(
0.00%
)
US TECH 100
19,196.00
(
-0.43%
)
Dow Jones
42,196.52
(
0.00%
)
Brent Oil
75.63
(
1.35%
)
Bitcoin
60,005.00
(
-1.02%
)
Post# of 253269
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

biomaven0

Send PM Follow Ignore
Followers 82
Posts 4778
Boards Moderated 0
Alias Born 02/27/2007

biomaven0

Re: mcbio post# 211356

Tuesday, 05/16/2017 10:53:32 PM

Tuesday, May 16, 2017 10:53:32 PM

Post# of 253269
There is a pretty close analogy with the Vifor Micerva deal:

http://www.roche.com/investors/updates/inv-update-2015-05-28.htm

I am informed that only a minority of the Fresenius patients in fact use Micerva rather than other EPOs.

Based on my understanding, the AKBA PR does indeed seem pretty misleading.

Peter




Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up